A

Axogen
D

AXGN

17.990
USD
-0.51
(-2.73%)
مغلق
حجم التداول
8,576
الربح لكل سهم
0
العائد الربحي
-
P/E
-55
حجم السوق
791,708,579
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ALGN
    -7.520
    (-3.80%)
    190.370 USD
    BSX
    BSX
    -0.840
    (-0.80%)
    104.480 USD
    EW
    EW
    -1.380
    (-1.85%)
    73.300 USD
    ISRG
    ISRG
    -15.37
    (-2.53%)
    591.50 USD
    JNJ
    JNJ
    2.680
    (1.68%)
    162.370 USD
    MDT
    MDT
    2.000
    (2.27%)
    89.940 USD
    M
    MMSI
    -2.470
    (-2.34%)
    103.150 USD
    SYK
    SYK
    -3.72
    (-0.96%)
    382.74 USD
    TMO
    TMO
    -5.71
    (-1.06%)
    532.28 USD
    ZBH
    ZBH
    1.250
    (1.21%)
    104.890 USD
    المزيد
الأخبار
المقالات

العنوان: Axogen

القطاع: Healthcare
الصناعة: Medical Devices
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.